No abstract available
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Adrenergic beta-Antagonists / therapeutic use
-
Animals
-
Anti-Arrhythmia Agents / therapeutic use
-
Calsequestrin / genetics
-
Defibrillators, Implantable
-
Electrocardiography
-
Flecainide / therapeutic use
-
Humans
-
Mutation
-
Phenotype
-
Ryanodine Receptor Calcium Release Channel / genetics
-
Sympathectomy
-
Tachycardia, Ventricular / diagnosis
-
Tachycardia, Ventricular / genetics*
-
Tachycardia, Ventricular / physiopathology
-
Tachycardia, Ventricular / therapy
-
Verapamil / therapeutic use
Substances
-
Adrenergic beta-Antagonists
-
Anti-Arrhythmia Agents
-
CASQ2 protein, human
-
Calsequestrin
-
Ryanodine Receptor Calcium Release Channel
-
casq2 protein, mouse
-
Verapamil
-
Flecainide
Supplementary concepts
-
Polymorphic catecholergic ventricular tachycardia